Little is known about the prognostic value of q wave abnormality for cardiovascular disease (CVD) on a resting electrocardiogram (ECG) of the Japanese general population with an extremely low incidence of myocardial infarction. Methods: We followed 8,339 participants without a past and present history of CVD for 19 years. The multivariate-adjusted hazard ratio (HR) of q wave abnormality for CVD mortality was estimated by the Cox proportional hazards model. Results: The multivariate-adjusted HR of composite findings of moderate or severe q wave abnormality was 1.75 (95% confidence interval (CI): 0.97 − 3.17) for mortality due to CVD and 2.97 (95%CI: 1.43 − 6.16) due to heart diseases. The multivariate-adjusted HR of mild abnormality for mortality from heart diseases was 1.95 (95%CI: 1.00 − 3.81). The relationship between moderate or severe abnormalities and mortality from CVD was unchanged when participants with ST-T changes and high amplitude R waves were excluded and when participants were divided by the presence of major CVD risk factors such as hypertension. Q wave abnormality was not associated with the risk of stroke. Conclusion: Moderate or severe q wave abnormalities are prominent and important predictors of mortality due to CVD and heart disease in the Japanese general population without CVD history. 
Introduction
Resting electrocardiogram (ECG) abnormalities such as q or ST-T wave abnormality classified by the Minnesota code (MC) have consistently been associ-In previous studies performed in the community, abnormality of q, ST, and T waves, left bundle branch block (LBBB) and high amplitude R waves were categorized into major or minor abnormalities to assess the risk for CVD or coronary heart disease (CHD) 7, 8) , and only a few studies assessed q wave abnormality by the grade of MC respectively 1, 5) . The assessment of q wave by grade is necessary to determine whether even a small q wave of an individual in the community without a history of cardiac event is a predictor for CVD. Moreover, a question remains whether the risk of q wave abnormality on CVD and its subtypes are independent of ST-T abnormality and high amplitude R waves.
To investigate the independent prognostic value of q wave for mortality due to CVD and its subtypes, we analyzed the data from a 19-year prospective study of 8,339 Japanese citizens free from CVD history at baseline.
Subjects and Methods

Study Participants
We used data from the National Integrated Project for Prospective Observation of Non-communicable Diseases and its Trends in the Aged, 1980 (NIPPON DATA80). Details of the study have been described elsewhere [9] [10] [11] [12] [13] [14] [15] . In this survey, 300 areas were selected by stratified random sampling based on the national census in 1975. All residents aged 30 years or older in these areas were enrolled, and 10,546 people participated in the survey (response rate: 76.6%). Accordingly, these participants were considered to be reasonably representative of the Japanese population.
In this study, we enrolled 8,339 participants (3,694 male and 4,645 female) who were free from CVD history, atrial fibrillation (Minnesota Code (MC), , Wolff-Parkinson-White syndrome (MC, 6-4-1), and complete LBBB (MC, 7-1).
Case Identification
To determine causes of death after 19-year follow up, we used the National Vital Statistics database of Japan with permission from the Management and Coordination Agency, Government of Japan. The underlying causes of death were coded according to the 9th International Classification of Disease (ICD-9) through the end of 1994 and the 10th International Classification of Disease (ICD-10) from the beginning of 1995. The details of the disease classification in the present study were previously reported 16, 17) , and the names of the diseases according to the classification of ICD-9 and -10 are shown in Table 1 . CVD (ICD 9 code: 393 to 459), stroke (ICD 9 code: 430 to 438), and heart disease (ICD 9 code: 393 to 398, 410 to 414, 415 to 429) were identified. Approval for this study was obtained from the Institutional Review Board of Shiga University of Medical Science (No. [12] [13] [14] [15] [16] [17] [18] 2000) .
Baseline Examination
Information on the history of CVD, diabetes, medication for hypertension, and the habits of smoking and drinking were obtained from interviews by public health nurses. Blood pressure was measured after five minutes' rest by trained public health nurses at each public health center using a standard mercury sphygmomanometer. Serum total cholesterol levels were determined in a laboratory (Osaka Medical Center for Health Science and Promotion) under the quality control program of the Center for Disease Control and Prevention in the United States 18) . Casual glucose concentration was measured by the cupric-neocuproine method 19) . Original glucose values obtained by the cupric-neocuproine method were converted to those of the glucose-oxidase method, which is currently the standard, by use of an equation reported by the same laboratory 20) . A standard 12-lead ECG was recorded in the supine position. Each ECG was coded independently by two researchers according to the Minnesota Code, which was developed to document significant ECG pattern changes using objective comparison rules 21) . Codes in agreement were accepted, whereas inconsistent codes were decided by a panel of epidemiologists and cardiologists 16) . Participants were divided into three categories according to the q wave abnormality grade as follows: q wave normal, mild q wave abnormality (MC, 1-3), and moderate or severe abnormality (MC, 1-1 and 1-2). Moderate or severe abnormalities were included in one group because the number of participants with moderate or severe abnormality was small.
Diagnosis of the presence of hypertension was systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or current medication for hypertension 22) . Because most participants had not fasted when the baseline survey was conducted, we defined hyperglycemia as a casual glucose level ≥ 140 mg/dL or a history of diabetes mellitus 23) . Diagnosis of hyperlipidemia was defined as serum total cholesterol ≥ 200 mg/dL 24) .
Statistical Analysis
To compare baseline characteristics between participants with and without q wave abnormality, we used analysis of variance or the chi-square test. Age was adjusted by analysis of covariance for continuous variables.
We used the Cox proportional hazards model to estimate hazard ratios (HR) of the presence of q wave abnormality for CVD mortality and its subtypes (stroke or heart disease). In this model, we included age at study entry, sex, body mass index (BMI), systolic blood pressure, serum total cholesterol, smoking (current or non-current), alcohol drinking (current or non-current), and the presence of hyperglycemia as confounding factors.
Further analysis was performed after exclusion for ST depression (MC, 4-1 to 4-4), T wave abnormality (MC, 5-1 to 5-4), and high amplitude R waves (MC, 3-1 to 3-3) from the source population 3, 25) . When we divided the participants according to the presence of hypertension, hyperglycemia, and hyperlipidemia, similar analysis was performed.
Results
Baseline Characteristics
The baseline characteristics of the participants with and without q wave abnormality for both sexes are shown in Table 2 . The number of study participants with mild q wave abnormality comprised 62 (1.7%) men and 46 (1.0%) women. The number of study participants with moderate or severe q wave abnormality comprised 23 (0.6%) men (moderate: 14, severe: 9) and 13 (0.3%) women (moderate: 10, severe: 3). Age and the percentages of a history of diabetes and hyperglycemia were significantly higher in those with q wave abnormality for both sexes. Systolic blood pressure, the percentages of hypertension and medication for hypertension, and serum total cholesterol were higher in those with q wave abnormality in men. Casual glucose level was higher in those with q wave abnormality in women. Although age adjustment slightly attenuated these relations, most relations remained statistically significant.
Risk of Q Wave Abnormality for CVD Mortality and its Subtypes
There were 1578 deaths among participants, including 544 deaths due to CVD, 257 deaths due to all stroke and 257 deaths due to heart diseases. Table 3 shows age-adjusted and multivariateadjusted HRs for CVD death and cause-specific mortality. On the whole, age-adjusted and multivariateadjusted HRs were almost the same as death from CVD and its subtypes. Among the participants with moderate or severe q wave abnormality, multivariateadjusted HR for CVD deaths compared to those without q wave abnormality was 1.79 (95%CI: 0.87 − 3.65) in men and 1.69 (95%CI: 0.54 − 5.29) in women. Since there was no apparent interaction between sex for CVD mortality or its subtypes, we combined men and women. For overall participants, the HR of moderate or severe q wave abnormality was 1.75 (95%CI: 0.97 − 3.17) for death due to CVD, 0.48 (95%CI: 0.12 − 2.00) due to stroke, 2.97 (95%CI: 1.43 − 6.16) due to heart diseases.
The multivariate-adjusted HR of participants with mild q wave abnormality for CVD death compared to those without q wave abnormality was 1.27 (95%CI: 0.60 − 2.71) in men and 1.87 (95%CI: 0.92 − 3.80) in women. For overall participants, the HR of mild q wave abnormality was 1.50 (95%CI: 0.90 − 2.51) for death due to CVD, 1.05 (95%CI: 0.43 − 2.56) due to stroke, 1.95 (95%CI: 1.00 − 3.81) due to heart diseases.
For all-cause mortality, multivariate-adjusted HRs of moderate or severe q wave abnormality and mild q wave abnormality were 1.62 (95%CI: 1.05 − 2.50), and 1.28 (95%CI: 0.92 − 1.80) respectively.
After additionally excluding participants with complete A-V block (MC, 6-1), right bundle branch block (MC, 7-2), and persistent ventricular rhythm (MC, 8-2), the HRs and 95%CIs of moderate or severe q wave abnormality were 1.87 (95%CI: 1.03 − 3.38) for CVD mortality and 3.20 (95%CI: 1.55 − 6.63) for heart disease mortality. Similarly, the HRs of mild q wave abnormality for CVD and heart disease mortality were 1.47 (95%CI: 0.86 − 2.51) and 1.82 (95%CI: 0.90 − 3.70), respectively.
Risk of Q Wave Abnormality After Exclusion of other ECG Abnormalities
As shown in Table 4 , multivariate-adjusted HRs of moderate or severe q wave abnormality for mortality from CVD and heart diseases were significantly elevated even when participants with ST depression, T wave abnormality and high amplitude R waves were excluded. In similar analysis, multivariate-adjusted HRs of mild q wave abnormality were almost the same; however, the relationship was not statistically significant. Table 5 shows age-adjusted and multivariateadjusted HRs for CVD death and heart disease mortality according to q wave abnormality when participants were divided by the presence of hypertension, hyperglycemia, and hyperlipidemia, respectively. For mortality from stroke, we did not perform further Values in parentheses indicate 95% confidence interval of hazard ratios. indicates statisitically significant difference compared to the reference. Age-adjusted hazard ratio: the grade of the q wave abnormality and age at study entry were entered in the model. Sex was also included in the model when we estimated overall hazard ratio. Multivariate-adjusted hazard ratio: grade of q wave abnormality, age at study entry, systolic blood pressure, body mass index, serum total cholesterol, smoking, alcohol drinking, and the presence of hyperglycemia (casual glucose ≥ 140 mg/dL and/or a history of diabetes mellitus) were entered in the model. Sex was also included in the model when we estimated overall hazard ratio.
Risk of Q Wave Abnormality According to the Presence of Major CVD Risk Factors
(1-3-) or (1-1-) (1-2-) indicates ECG codes classified by Minnesota Codes. Values in parentheses indicate 95% confidence interval of hazard ratios. indicates statisitically significant difference compared to the reference. Age-adjusted hazard ratio: grade of q wave abnormality, sex, and age at study entry were entered in the model. Multivariate-adjusted hazard ratio: grade of q wave abnormality, sex, age at study entry, systolic blood pressure, body mass index, serum total cholesterol, smoking, alcohol drinking, and a hyperglycemia (casual glucose ≥ 140 mg/dL and/or a history of diabetes mellitus) were entered in the model. Sex was also included in the model when we estimated overall hazard ratio.
( analysis because there was no significant relationship between q wave abnormality and mortality from stroke after multivariate adjustment, as shown in Table 3 , 4. Among most of these subgroups, HRs of moderate or severe q wave abnormality for mortality from CVD and heart disease were significantly elevated, and those of mild abnormality were elevated although the relationship did not reach statistical significance.
Discussion
Our study presented the risk of q wave abnormality by the grade of MC for CVD mortality and its subtypes among Japanese general population who were free from CVD history. Although the prevalence of moderate or severe q wave abnormality was low (0.4%), a significant increase of HRs was observed among participants with moderate or severe q wave abnormality for heart disease mortality. HRs of moderate or severe q wave abnormality for mortality from CVD and heart disease were also significantly elevated when participants with ST, T wave abnormality and high amplitude R waves were excluded. Furthermore, when participants were divided into subgroups according to the presence of hypertension, hyperglycemia, and hyperlipidemia, HRs of moderate or severe q wave abnormality for mortality due to CVD and heart disease were also consistently elevated. Q wave abnormality was not associated with the risk of stroke mortality.
Previous studies have reported that major q wave abnormality (MC, 1-1) predicts all-cause and CVD mortality 2) ; however, few studies have reported the risk of q wave abnormality by grade. Rose et al. reported that age-adjusted coronary heart disease mortality increased according to the grade of q wave in their five-year follow-up study 5) , but they did not assess multivariate-adjusted HR of q wave abnormality.
Our study is the first report to present the risk of q wave by grade, independent from ECG abnormalities such as ST-T abnormality and high amplitude R waves and other CVD risk factors. A previous study reported that even minor ST-T abnormalities were associated with increased long-term risk of mortality or incidence due to stroke, CHD, and CVD 3, 26) . As we reported previously, high left R waves are associated with CVD mortality 25) . Accordingly, we excluded participants with ST-T wave abnormality and high amplitude R waves to assess the risk of q wave abnormality independent of other ECG abnormalities. Participants with moderate or severe q wave abnormality showed a significant increase of HR for CVD and heart disease even when ST-T wave abnormality and high amplitude R waves were excluded. People in the community with MC 1-1 and MC 1-2 are considered to be a high-risk group for death due to CVD or heart diseases regardless of ST-T change and high R waves, and should be studied to determine the specific etiology.
The risk of q wave abnormality was assessed according to the presence of three major CVD risk factors. Essentially, moderate or severe q wave abnor- Values in parentheses indicate 95% confidence interval of hazard ratios. indicates statisitically significant increase compared to the reference. Diagnosis of hypertension: systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥ 90 mmHg and/or current medication for hypertension. Diagnosis of hyperglycemia: casual glucose ≥ 140 mg/dL and/or a history of diabetes mellitus. Diagnosis of hyperlipidemia: total cholesterol ≥ 200 mg/dL. Age-adjusted hazard ratio: grade of q wave abnormality, sex, and age at study entry were entered in the model. Multivariate-adjusted hazard ratio: grade of q wave abnormality, sex, age at study entry, systolic blood pressure, body mass index, serum total cholesterol, smoking habit, alcohol drinking, and the presence of hyperglycemia (casual glucose ≥ 140 mg/dL and/or a history of diabetes mellitus) were entered in the model. malities were associated with the risk of mortality due to CVD or heart diseases regardless of the presence of three major CVD risk factors. The vast majority of abnormal q waves are due to myocardial infarction, but a significant number is due to other causes, such as cardiomyopathy, chronic obstructive lung disease 4) and in patients with nephropathy 27) . ECG screening is a simple, inexpensive and widely available test compared to the various specific tests to screen people with those diseases in communities. Moreover, ECG is able to increase the predictive value to identify individuals at high-risk for CVD and heart disease mortality in addition to classic CVD risk factors.
The participants in this study were from a nationwide cohort study and were selected by a stratified random sampling method. Accordingly, the results of the present study would apply to the general Japanese population. Furthermore, the participants in our study were observed for 19 years, which is a long follow-up period and increases the value of our study substantially.
One of the limitations of our study is that the number of participants with q wave abnormality was small. Accordingly, we could not divide the participants into three q wave categories (MC, 1-1, 1-2, and 1-3) and assess the risk of q wave abnormality according to the subtypes of stroke and heart diseases. We also could not investigate the prognostic value of mild q wave abnormality sufficiently in this study. Secondly, MC was coded by visual reading in our study. Computerized ECG analysis is reportedly superior to visual reading for better reliability 28) ; however, ECG reading in this study was performed under the best standardized quality control in 1980. Third, we could not assess the risk of q wave abnormalities according to the lead in which q waves were present to evaluate their clinical meaning because there were no data concerning the lead in the baseline survey.
In conclusion, moderate or severe q wave abnormality is associated with an elevated risk of mortality from CVD or heart diseases independent of other ECG changes among participants with no CVD history. Although the prevalence of q wave abnormality is not high among participants without a history of CVD in communities, q wave abnormality is a prominent and important predictor of CVD and heart disease mortality.
